TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010
TCL Archive After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big December 2, 2011